Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY:DHR)

168.88 +2.89 (+1.74%)
Streaming Delayed Price Updated: 10:08 AM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
News headline image
3 Profitable Stocks We’re Skeptical Of
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
This Stock Is Up Over 52,700% Since Founding. Should Investors Buy After Its 36% Decline? ↗
This blue chip stock has been in a multiyear slump, but things are looking up. 
Via The Motley Fool
Topics Artificial Intelligence
Top gainers and losers in the S&P500 index during Thursday's after-hours session. ↗
Via Chartmill
Thursday's after hours session: top gainers and losers ↗
Via Chartmill
Discover which S&P500 stocks are making waves on Wednesday. ↗
Via Chartmill
News headline image
DHR Q1 Deep Dive: Bioprocessing Momentum and Acquisition Strategy Drive Mixed Start to 2026
Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.7% year on year to... 
Via StockStory
News headline image
Danaher (DHR) Q1 2026 Earnings Call Transcript ↗
Danaher (DHR) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Danaher Corp. May Be the Smartest Bet in Biotech Right Now ↗
If biotech funding continues to increase this year, Danaher could benefit. 
Via The Motley Fool
Topics Supply Chain
News headline image
Danaher (NYSE:DHR) Misses Q1 CY2026 Revenue Estimates
Diversified science and technology company Danaher (NYSE:DHR) fell short of the market’s revenue expectations in Q1 CY2026 as sales rose 3.7% year on year to... 
Via StockStory
News headline image
Danaher (DHR) Q1 Earnings: What To Expect
Diversified science and technology company Danaher (NYSE:DHR) will be reporting results this Tuesday before market open. Here’s what to expect. Danaher met a... 
Via StockStory
Topics Artificial Intelligence
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron... 
Via StockStory
News headline image
AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
From AINewsWire
Via GlobeNewswire
News headline image
Hologic, Inc. (NASDAQ: HOLX): A New Chapter as a Women’s Health Powerhouse
Today marks a definitive turning point for Hologic, Inc. (NASDAQ: HOLX). As the company prepares to finalize its $18.3 billion acquisition by private equity giants Blackstone and TPG, it stands as a... 
Via Finterra
Topics Artificial Intelligence Retirement World Trade
News headline image
3 Reasons to Avoid DHR and 1 Stock to Buy Instead
Although the S&P 500 is down 2.8% over the past six months, Danaher’s stock price has fallen further to $190.75, losing shareholders 9.3% of their capital. T... 
Via StockStory
Topics Stocks
News headline image
The Often-Missed Corner of Healthcare That Wall Street Is Loving ↗
Via MarketBeat
News headline image
Spotting Winners: Danaher (NYSE:DHR) And Research Tools & Consumables Stocks In Q4
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Danaher (NYSE:DHR) and its peers. Th... 
Via StockStory
Topics Economy
News headline image
1 S&P 500 Stock Worth Your Attention and 2 Facing Headwinds
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all ... 
Via StockStory
Topics Stocks
News headline image
The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal
As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise.... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
As the first quarter of 2026 draws to a close, the healthcare and life sciences sectors are grappling with a "new normal" defined by capital conservatism and geopolitical friction. Industry... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
1 Profitable Stock to Target This Week and 2 We Avoid
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Masimo Corporation (Nasdaq – MASI), IHS Holding Limited (NYSE – HIS), VerifyMe, Inc. (Nasdaq – VRME), Great Lakes Dredge & Dock Corporation (Nasdaq – GLDD)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026
WALTHAM, MA — In a market defined by shifting geopolitical alliances and a renewed "flight to quality," Thermo Fisher Scientific (NYSE:TMO) has once again asserted its dominance as the bedrock of the... 
Via MarketMinute
Topics Earnings Economy World Trade
News headline image
The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗
As AI uncertainty weighs on stocks, consider loading up on these dividend-growth blue chips instead. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire... 
Via MarketMinute
News headline image
Danaher’s $9.9 Billion Acquisition of Masimo: A Strategic Pivot to the Future of Patient Monitoring
In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Naya Capital Adds Masimo Shares ↗
Masimo supplies noninvasive monitoring tech to hospitals and care providers, serving both medical and consumer health markets worldwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 of Wall Street’s Favorite Stock with Exciting Potential and 2 We Find Risky
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
Billionaire Investors Warren Buffett, Bill Ackman and Other Have Been Buying These Stocks ↗
Every quarter, we get to see what the best of the best have bought and sold. 
Via The Motley Fool
News headline image
Danaher's $9.9 Billion Bet: Masimo Acquisition to Redefine the Diagnostics Landscape
In a move that signals a massive consolidation in the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to... 
Via MarketMinute
Topics Artificial Intelligence Economy
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.